Covid-19 Vaccine: A rebalancing event

About the author:

Andrew Tang
Author name:
By Andrew Tang
Job title:
Analyst - Equity Strategy
Date posted:
12 November 2020, 5:10 PM
Sectors Covered:
Equity Strategy and Quant

We highlight opportunities to rebalance your portfolio – stocks you could potentially trim to provide a funding source for the re-opening trade:

More sector analysis on vaccine news

Find out more

Morgans clients can access my full report: "Not less than zero" by logging into the client website. Alternatively you can browse further analysis in the research section of the site.

Browse latest research

Need access to our research?

You are also welcome to start a two-week trial of our online platform, which provides access to detailed market analysis and insights, provided by our award-winning research team. Please contact your Morgans adviser or nearest Morgans office for further assistance.

Create trial account  Find local branch

Disclaimer: The information contained in this report is provided to you by Morgans Financial Limited as general advice only, and is made without consideration of an individual's relevant personal circumstances. Morgans Financial Limited ABN 49 010 669 726, its related bodies corporate, directors and officers, employees, authorised representatives and agents (“Morgans”) do not accept any liability for any loss or damage arising from or in connection with any action taken or not taken on the basis of information contained in this report, or for any errors or omissions contained within. It is recommended that any persons who wish to act upon this report consult with their Morgans investment adviser before doing so.

  • Print this page
  • Copy Link